Role of epidermal growth factor receptor inhibitors in the treatment of lung cancer

Targeted Therapy in Non-Small Cell Lung Cancer: Review Article

In silico analysis revealed the prognostic potential of a miRNA panel in lung carcinoma

Tumor-derived Vascular Endothelial Growth Factor and Angiopoietin-2 in Non-small Cell Lung Cancer

Altered expression of miRNA-155 and miRNA-21 and higher numbers of T cells in the peripheral blood of early diagnosed lung cancer patients

The crucial role of long non-coding RNAs in the pathogenesis, therapeutic response, and clinical implications of esophageal cancer

Study the effect of FGFR2 and FGFR4 gene variants on the response to cyclophosphamide doxorubicin-docetaxel based chemotherapy in locally advanced breast cancer patients

Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer

Sulforaphane Can Intensify The Antitumor Effect Of Gemcitabine By Targeting Cancer Stem Cells In Non-small Cell Lung Cancer Via Suppressing TGF-β1/TNF-α Factor

Circulating Cancer Cells with Relative Expression of miRNA and Cytotoxic T-cell Activities in Non-small cell Lung Cancer Patients: PhD Thesis Abstract